Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Men with testicular cancer were less likely to experience baldness and severe acne.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Certain nutrients can help keep skin healthy as we age.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

Men with moderate hair loss had the best spatial thinking, and long-term DHT might affect cognition.

Finasteride doesn't change polycystic ovary size or cyst number, suggesting testosterone's role in their appearance.

Herbal formula shows promise for hair loss treatment.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Older age, family history, and low iron levels increase the risk of female hair loss.

PCOS affects many women and requires early detection and symptom management.

Skin issues are common and important for diagnosing PCOS.

Herbal treatments can help manage PCOS symptoms.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.